Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 손경복 | - |
dc.date.accessioned | 2019-07-31T16:30:01Z | - |
dc.date.available | 2019-07-31T16:30:01Z | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1744-8603 | - |
dc.identifier.other | OAK-25032 | - |
dc.identifier.uri | https://dspace.ewha.ac.kr/handle/2015.oak/250331 | - |
dc.description.abstract | Background: Recently, interest in compulsory licensing of pharmaceuticals has been growing regardless of a country's income- level. We aim to investigate the use of compulsory licensing as a legitimate part of the patent system and tool for the government to utilize by demonstrating that countries with a mature patent system were more likely to utilize compulsory licensing of pharmaceuticals. Methods: We used a multivariate logistic model to regress attempts to issue compulsory licensing on the characteristics of the intellectual property system, controlling for macro context variables and other explanatory variables at a country level. Results: A total 139 countries, selected from members of the World Trade Organization, were divided into a CL-attempted group (N = 24) and a non-CL-attempted group (N = 115). An attempt to issue compulsory licensing was associated with population (+) and a dummy variable for other regions, including Europe and North America (-). After controlling for macro context variables, mature intellectual property system was positively associated with attempting compulsory licensing. Conclusions: Our study provided evidence of an association between attempting compulsory licensing and matured patent systems. This finding contradicts our current understanding of compulsory licensing, such as compulsory licensing as a measure to usurp traditional patent systems and sometimes diametrically opposed to the patent system. The findings also suggest a new role of compulsory licensing in current patent systems: compulsory licensing could be a potential alternative or complement to achieve access to medicines in health systems through manufacturing and exporting patented pharmaceuticals. © 2019 The Author(s). | - |
dc.language | English | - |
dc.publisher | BioMed Central Ltd. | - |
dc.subject | Access to medicines | - |
dc.subject | Compulsory licensing | - |
dc.subject | Intellectual property | - |
dc.subject | Patent system | - |
dc.title | Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: A cross-sectional analysis | - |
dc.type | Article | - |
dc.relation.issue | 1 | - |
dc.relation.volume | 15 | - |
dc.relation.index | SCIE | - |
dc.relation.index | SSCI | - |
dc.relation.index | SCOPUS | - |
dc.relation.journaltitle | Globalization and Health | - |
dc.identifier.doi | 10.1186/s12992-019-0485-7 | - |
dc.identifier.wosid | WOS:000473182400001 | - |
dc.identifier.scopusid | 2-s2.0-85068484027 | - |
dc.author.google | Son K.-B. | - |
dc.contributor.scopusid | 손경복(57194473538) | - |
dc.date.modifydate | 20230208101201 | - |